ArticleFrontiers in immunology2021

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease.

Marta Arbrile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.